Advertisement

Topics

Marshall Edwards Company Profile

12:39 EDT 19th June 2018 | BioPortfolio

Marshall Edwards, Inc. ('MEI') is a pharmaceutical company dedicated to the field of cancer therapy (oncology).MEI is developing a range of anti-cancer therapies that represents the next generation of oncology drugs - multiple signal transduction regulators (abbreviated as 'MSTRs') that reach to the heart of the cancer process.
The source of this new range of drugs is a family of chemicals, discovered by pharmaceutical company Novogen, that act against the fundamentals of the cancer process. Using this single technology platform, MEI is developing a number of drugs with novel actions against a range of different cancer types.
The first of these drugs - Phenoxodiol - has advanced to Phase II clinical studies.

Location

140 Wicks Road
North Ryde
New South Wales
2113
Australia

Contact

Phone: 61 2 8877 6196
Fax: 61 2 9878 8474
Email: meiinformation@marshalledwardsinc.com


News Articles [155 Associated News Articles listed on BioPortfolio]

Marshall School of Medicine receives multi-million dollar grant to research obesity

(Marshall University Joan C. Edwards School of Medicine ) The Marshall University Joan C. Edwards School of Medicine has received a $10.78 million grant from the National Institutes of Health to resea...

Investigators probe motive in deadly Kentucky school shooting

Police have not yet identified the gunman or released any information about what motivated the Tuesday morning attack at Marshall County High School in Benton, Kentucky, about 120 miles (190 km) north...

Edwards Lifesciences Updates FY18 Guidance

WASHINGTON (dpa-AFX) - Edwards Lifesciences Corp. (EW) announced, for the full year 2018, given the company's sales momentum and current foreign exchange rates, Edwards increased its sales estimat...

Boston Scientific Prevails In European Patent Dispute With Edwards Lifesciences

European Patent Office Revokes Edwards Lifesciences '550 Patent MARLBOROUGH, Mass., April 16, 2018 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it, along with sever...

Edwards Lifesciences Corp (EW) VP Sells $762,300.00 in Stock

Edwards Lifesciences Corp VP Larry L. Wood sold 6,300 shares of Edwards Lifesciences stock in a transaction dated Tuesday, January 16th. The shares were sold at an average price of $121.00, for a tota...

Evotec-Aktie: Starker Rückzug von Leerverkäufer Marshall Wace geht weiter

Hamburg - Leerverkäufer Marshall Wace LLP reduziert Netto-Leerverkaufsposition in Aktien der Evotec AG wieder spürbar: Die Leerverkäufer des Hedgefonds Marshall Wace LLP ziehen sich aus ihrem Short...

MorphoSys-Aktie: Leerverkäufer Marshall Wace hat sich deutlich zurückgezogen

Martinsried (www.aktiencheck.de) - Leerverkäufer Marshall Wace hat Netto-Leerverkaufsposition in MorphoSys-Aktien spürbar verringert: Die Leerverkäufer des Hedgefonds Marshall Wace LLP befinden sic...

Evotec-Aktie: Spürbarer Rückzug von Leerverkäufer Marshall Wace

Hamburg - Leerverkäufer Marshall Wace LLP baut Netto-Leerverkaufsposition in Aktien der Evotec AG signifikant ab: Die Leerverkäufer des Hedgefonds Marshall Wace LLP befinden sich kontinuierlich im ....

PubMed Articles [32 Associated PubMed Articles listed on BioPortfolio]

Transfemoral aortic valve implantation is more successful with the Edwards Sapien 3 compared with the Edwards XT for the treatment of symptomatic severe aortic stenosis.

Residual aortic regurgitation (AR) after transfemoral aortic valve implantation (TAVI) is associated with increased mortality. The new Edwards Sapien 3 valve (ES3) is designed to reduce paravalvular A...

Randomized trial of the Carpentier-Edwards supra-annular prosthesis versus the Medtronic Mosaic aortic prosthesis: 10-year results.

We performed a prospective randomized study comparing the clinical performance of the Carpentier-Edwards supra-annular valve (CE-SAV) (Edwards Lifesciences, Irvine, CA, USA) and the newer Mosaic (Medt...

Profesor Dr. Marshall Raymond Urist (1914-2001): descubridor de la formación ósea por inducción.

Marshall R. Urist was an American orthopedic surgeon who worked in University of California at Los Angeles. His scientific work about bone formation brought to medical science the discovery of a bone ...

Selective ablation of the ligament of Marshall attenuates atrial electrical remodeling in a short-term rapid atrial pacing canine model.

Cardiac sympathetic activation facilitates atrial electrical remodeling during atrial fibrillation (AF). Selective ablation of the distal part of the ligament of Marshall (LOM ) could decrease cardiac...

Edwards Sapien XT® pulmonic valve compression after resuscitation and successful redilatation.

Despite the increasing use of percutaenous valves, little is known about valve performance after external chest compression. We report a case of a compressed pulmonary Edwards Sapien® XT valve after ...

Clinical Trials [69 Associated Clinical Trials listed on BioPortfolio]

EDWARDS INTUITY Valve System CADENCE-MIS Study

The study purpose is to compare the EDWARDS INTUITY valve system in a minimal invasive surgical approach (MIS) with any commercially available aortic bioprosthesis in standard full ster-no...

EDWARDS INTUITY Valve System CADENCE Study

The study purpose is to compare the EDWARDS INTUITY valve system with commercially available stented aortic bioprostheses, in patients requiring aortic valve replacement surgery with coron...

Multicenter Trial of Congenital Pulmonic Valve Dysfunction Studying the SAPIEN 3 THV With the Alterra Adaptive Prestent

To demonstrate the safety and functionality of the Edwards Alterra Adaptive Prestent in conjunction with the Edwards SAPIEN 3 Transcatheter Heart Valve (THV) System in patients with a dysf...

Medtronic's MOSAIC Bioprosthesis Versus Baxter Carpentier-Edwards SAV Porcine Valve

The study compares the clinical performance of the Mosaic valve with that of the Baxter valve (Carpentier-Edwards) which is widely used throughout the UK and is considered to be the "bench...

CardiAQ-Edwards™ Transcatheter Mitral Valve Replacement (TMVR) Study

Clinical study to evaluate the safety and performance of the CardiAQ-Edwards™ Transcatheter Mitral Valve

Companies [37 Associated Companies listed on BioPortfolio]

Marshall Edwards, Inc.

Marshall Edwards

Marshall Edwards, Inc. ('MEI') is a pharmaceutical company dedicated to the field of cancer therapy (oncology).MEI is developing a range of anti-cancer therapies that represents the next generation of...

Edwards Lifesciences Corporation

Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring. Headquartered in Irvine, Calif., Edwards treats advanced cardiovascular disease with its marke...

Edwards Ltd

Further information about Edwards can be found at www.edwardsvacuum.com.

Recombinant Capital

Recombinant Capital (Recap) is a San Francisco Bay Area-based consulting firm specializing in biotechnology alliances, earned alliance revenues, product sales, employment agreements, company informati...

More Information about "Marshall Edwards" on BioPortfolio

We have published hundreds of Marshall Edwards news stories on BioPortfolio along with dozens of Marshall Edwards Clinical Trials and PubMed Articles about Marshall Edwards for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Marshall Edwards Companies in our database. You can also find out about relevant Marshall Edwards Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...


Corporate Database Quicklinks



Searches Linking to this Company Record